Clinical Trial Update: Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus Nephritis [Phase 3]

View source ↗

Summary

Phase 3 trial update on concentration-controlled therapy with mycophenolate mofetil for proliferative lupus nephritis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Chulalongkorn University | Conditions: Lupus Nephritis | Phase 3 | Status: COMPLETED